Stay updated on Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.
Latest updates to the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page
- Check5 days agoChange DetectedMelanoma and related topics such as MedlinePlus Genetics were added as related topics on the page.SummaryDifference0.2%
- Check12 days agoChange DetectedMelanoma and MedlinePlus Genetics were removed from the Related Topics section; these related-topic links are navigational aids rather than core trial content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check20 days agoChange DetectedRevision label updated from v3.2.0 to v3.3.2 on the page; this minor version update does not modify the study content or user-facing information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%
- Check27 days agoChange DetectedA government funding/operating status notice was removed, while the study details and contacts remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%
- Check34 days agoChange DetectedAdded related topic links: Melanoma and MedlinePlus Genetics.SummaryDifference0.2%
- Check41 days agoChange DetectedCore study details appear unchanged. The visible differences are minor layout/formatting changes that do not affect the study information.SummaryDifference0.4%
Stay in the know with updates to Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and Radiotherapy in Melanoma: Clinical Trial page.